Plus, stimulus negotiations are still going, Pfizer said it has set up its “biggest ever” logistics operation to distribute its COVID-19 vaccine candidate, and Nikola shares are up on hopes for its deal with GM.
Read MorePlus, stimulus negotiations are making little progress, Boeing shares are up after Europe’s top aviation official said the 737 MAX could return to the skies in the region before the end of the year, and Navistar shares are up on reports that it has agreed to a deal to merge with Traton.
Read MorePlus, the tussle over a stimulus deal continues, Morgan Stanley delivered an earnings beat, and Fastly shares plummet after delivering downbeat third-quarter guidance.
Read MorePlus, Delta reported a $5.4 billion loss, AMC said it could run out of money by early 2021 as movie theaters continue struggle amid the ongoing coronavirus, and Disney announced a reorganization to focus its media and entertainment business on streaming.
Read MoreEver since coronavirus found its way to American shores, a large amount of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names across the world have been working hard to develop effective treatments for the disease. From the market’s bearish low in […]
Read MorePlus, stimulus negotiations are still at an impasse, Twilio is buying consumer data infrastructure company Segment, and Mallinckrodt filed for bankruptcy.
Read MorePlus, there’s more confusion on the stimulus front, GE got a big upgrade from Goldman Sachs, and Disney’s newest Pixar film is skipping theaters.
Read MorePlus, jobless claims were worse than expected, Regeneron submitted an emergency use authorization request to the FDA for its antibody cocktail, and Morgan Stanley is buying Eaton Vance.
Read MorePlus, President Trump called off stimulus negotiations, Eli Lilly submitted a request to the FDA for emergency use authorization for its experimental COVID-19 antibody treatment, and GE got a Wells notice from the SEC.
Read MorePlus, Trump is back at the White House, House Speaker Pelosi and Treasury Secretary Mnuchin will resume stimulus negotiations today, and Apple announced a new product launch event for October 13 where it is expected to unveil new iPhone models.
Read MorePlus, AMC shares are down as movie theaters close with no big releases until the end of this year, Bristol-Myers Squibb is buying MyoKardia, and Nvidia is building a $52 million supercomputer for Cambridge.
Read MorePlus, initial jobless claims were lower than expected, AstraZeneca shares are down after the FDA said it’s expanding its inquiry into the serious illness of a participant in its COVID vaccine trial, and the CEOs of Facebook, Google, and Twitter will be subpoenaed for testimony by the Senate Commerce Committee.
Read MoreBuy Price: $3.00 or better Sell Price: TradersPro Sell Signal Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. It offers cephalosporin-based products, antibiotics of non- structure, and anti-cancer drugs in the form of injections, ampulla packaged products, child suspensions, tablets, and capsules. The company also […]
Read MorePlus, Goldman Sachs said fears that a delayed U.S. election result could upend the stock market are overblown, Novavax entered a late stage trial for its coronavirus vaccine candidate, and Amazon announced two new Fire TV sticks.
Read MorePlus, Johnson & Johnson started its phase three trial for its possible coronavirus vaccine, Nike shares are up after its earnings report, and Tesla shares are down after its disappointing Battery Day event.
Read More